Structure-antioxidative activity relationships in benzylisoquinoline alkaloids. 1995

B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
Departamento de QuĂ­mica, Facultad de Ciencias, Universidad de Chile, Santiago.

The antioxidative properties of the aporphines boldine, glaucine and apomorphine, and of the benzyltetrahydroisoquinolines (+/-)-coclaurine and (+/-)-norarmepavine were compared in the brain homogenate autoxidation model. The IC50 values found lay in the 16-20 microM range for the aporphines and were 131.7 microM, and 79.3 microM for coclaurine and norarmepavine, respectively. These results indicate that the antioxidative capacity (AC) of these compounds is related to the presence of the biphenyl system rather than phenol groups. The non-phenolic glaucine inhibited the 2,2'-azobis-(2-amidinopropane)(AAP)-induced inactivation of lysozyme with an IC50 value of 12 microM, while the corresponding values for the phenolic coclaurine and norarmepavine were 10 and 20 microM, respectively. N-Methylation of glaucine to its quaternary ammonium reduced its protective effect by two-thirds. This result suggests that a benzylic hydrogen neighbouring a nitrogen lone electron pair may be the key to the protective effect of non-phenolic aporphines.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001060 Aporphines Dibenzoquinolines derived in plants from (S)-reticuline (BENZYLISOQUINOLINES).
D001593 Benzyl Compounds Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R. Compounds, Benzyl
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
April 1987, Die Pharmazie,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
January 1978, Farmatsiia,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
December 1974, The Journal of pharmacy and pharmacology,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
February 1993, Planta medica,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
January 1998, Journal of agricultural and food chemistry,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
February 1992, Journal of ethnopharmacology,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
January 2019, Genes to cells : devoted to molecular & cellular mechanisms,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
July 2015, Molecules (Basel, Switzerland),
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
April 1998, Journal of natural products,
B K Cassels, and M Asencio, and P Conget, and H Speisky, and L A Videla, and E A Lissi
January 2005, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!